Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateMississippiIn Committee
HB 1152: Right to Try Medical Cannabis Act; create.
Lee Yancey
HB 1152 status: In Committee — Died In Committee (updated Apr 16, 2026).
Source
OpenStates
Confidence
Low
Analysis basis
OpenStates summary
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
55OUT OF 100
Score:55/100 civic fit
Risk:Moderate Risk
Impact:Moderate Impact 50/100
Constitutionality50%
Bipartisan50%
Public opinion70%
Bill summary
What changes
The bill would permit the use of medical marijuana by patients with serious illnesses even if the specific substance has not yet received full approval for general clinical use.
Who is affected
Patients suffering from serious illnesses, medical providers, and state healthcare regulatory agencies.
Requirements and enforcement
Not stated in the available source.
Costs and funding
Not stated in the available source.
When it takes effect
Not stated in the available source.
Potential benefits
Potential access to alternative treatments for individuals with serious conditions who may have exhausted other medical options.
Risks and tradeoffs
Public health safety risks associated with unverified drugs and a lack of standardized clinical trials for these specific applications.
What is still unknown
Specific mechanisms for physician involvement, supply chain regulation, and liability protections for providers are not disclosed in the summary.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
55%
Benefits
- potential growth in medical cannabis markets
- new patient access to specialized products
- increased demand for state-authorized providers
Risks
- uncertain compliance costs for businesses
- regulatory volatility for cannabis entities
- implementation costs for administrative oversight
Society
Positive outlook
65%
Benefits
- improved access for seriously ill populations
- potential quality of life improvements
- expanded autonomy for patient treatment choices
Risks
- risk of utilizing therapies without standard approval
- inequitable access depending on provider participation
- confusion regarding legal protections for patients
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Mixed / Neutral
45%
Benefits
- access to potential symptom relief for refractory cases
- expanded clinical treatment options
- autonomy for patients facing life-limiting illnesses
Risks
- health risks from using non-FDA approved substances
- lack of clinical data on long-term safety
- potential for adverse drug interactions
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
OpenStates
Official bill text or data from OpenStates.
Confidence
Low
Information is limited or incomplete.
Analysis basis
OpenStates summary
Source used for this bill's analysis.
Source note
Use of non-fully approved medical treatments poses clinical safety risks.
Analysis scope
Abstract provided; no full bill text reviewed.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.